Carl Schmid discusses ideas on how to minimize barriers and increase overall use of PrEP therapy in episode 13 of Managed Healthcare Executive’s “Evaluating the Current and Future Opportunities for HIV PrEP.”
Carl Schmid describes the steps that can be taken to reduce inequities in PrEP uptake, focusing on community and provider education in episode 14 of Managed Healthcare Executive’s “Evaluating the Current and Future Opportunities for HIV PrEP.”
This worshop will educate attendees about efforts to create national programs to increase the promotion of PrEP to those communities that are most in need of it, along with their providers. Additionally, ways in which PrEP can be covered and made affordable now and in the future by various payers including private insurers, Medicaid, and Medicare will be discussed. Implementation barriers will be identified along with potential steps that can be taken to overcome them. Ideas on how to provide PrEP to the uninsured and underinsured will also be explored. Attendees will have an opportunity to provide input on the proposals presented and learn what advocacy is needed to ensure the goal of increasing the uptake of PrEP, particularly in the communities most impacted by HIV, will be achieved.
Carl Schmid presents at National Association of Insurance Commissioners, along with other consumer representatives, on discrimination in insurance benefit design with a focus on prescription drugs and adverse tiering.
HIV+Hep’s Carl Schmid, a consumer representative to the National Association of Insurance Commissioners (NAIC), presents to the NAIC PBM subgroup, along with ACSCAN’s Anna Howard, on how PBM’s impact patient access and affordability of prescription drugs.